$338 Million is the total value of Sands Capital Ventures, LLC's 21 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 8.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | NU HLDGS LTD | $72,213,604 | +65.7% | 9,152,548 | -0.0% | 21.36% | +98.3% | |
| PATH | Sell | UIPATH INCcl a | $50,813,048 | -24.2% | 3,066,569 | -19.7% | 15.03% | -9.3% |
| DASH | DOORDASH INCcl a | $46,120,387 | +20.2% | 603,512 | 0.0% | 13.64% | +43.9% | |
| Sell | SAMSARA INC | $42,768,916 | -5.5% | 1,543,447 | -32.7% | 12.65% | +13.1% | |
| SNOW | Buy | SNOWFLAKE INCcl a | $37,960,294 | +14.1% | 215,708 | +0.1% | 11.23% | +36.6% |
| TXG | 10X GENOMICS INC | $26,902,037 | +0.1% | 481,770 | 0.0% | 7.96% | +19.8% | |
| ACRIVON THERAPEUTICS INC | $21,417,761 | +2.1% | 1,652,605 | 0.0% | 6.34% | +22.2% | ||
| ABOS | ACUMEN PHARMACEUTICALS INC | $16,436,131 | +18.5% | 3,417,075 | 0.0% | 4.86% | +41.8% | |
| OLK | OLINK HLDG ABsponsored ads | $13,228,388 | -16.8% | 705,514 | 0.0% | 3.91% | -0.4% | |
| TARS | TARSUS PHARMACEUTICALS INC | $4,698,200 | +43.8% | 260,000 | 0.0% | 1.39% | +72.0% | |
| SPRB | SPRUCE BIOSCIENCES INC | $1,692,065 | -2.7% | 787,007 | 0.0% | 0.50% | +16.3% | |
| MASS | Sell | 908 DEVICES INC | $1,627,590 | -42.0% | 237,258 | -27.3% | 0.48% | -30.7% |
| CANDEL THERAPEUTICS INC | $1,022,789 | -6.7% | 811,737 | 0.0% | 0.30% | +11.8% | ||
| TSHA | TAYSHA GENE THERAPIES INC | $478,416 | -17.5% | 724,873 | 0.0% | 0.14% | -0.7% | |
| CPNG | Buy | COUPANG INCcl a | $146,821 | +31.6% | 8,438 | +21.0% | 0.04% | +53.6% |
| Buy | TOAST INCcl a | $141,898 | +77.9% | 6,287 | +39.9% | 0.04% | +110.0% | |
| DDOG | DATADOG INC | $134,387 | +35.4% | 1,366 | 0.0% | 0.04% | +60.0% | |
| CRWD | Sell | CROWDSTRIKE HLDGS INCcl a | $109,271 | -7.9% | 744 | -13.9% | 0.03% | +10.3% |
| ABSCI CORPORATION | $87,862 | -13.1% | 57,804 | 0.0% | 0.03% | +4.0% | ||
| CFLT | CONFLUENT INC | $47,810 | +46.7% | 1,354 | 0.0% | 0.01% | +75.0% | |
| GITLAB INC | $33,630 | +49.0% | 658 | 0.0% | 0.01% | +66.7% | ||
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -58,895 | -100.0% | -2.64% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -2,748,970 | -100.0% | -19.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UIPATH INC | 9 | Q3 2023 | 30.2% |
| DOORDASH INC | 9 | Q3 2023 | 19.6% |
| SNOWFLAKE INC | 9 | Q3 2023 | 14.4% |
| ACUMEN PHARMACEUTICALS, INC | 9 | Q3 2023 | 10.0% |
| 908 DEVICES INC | 9 | Q3 2023 | 1.8% |
| TARSUS PHARMACEUTICALS INC | 9 | Q3 2023 | 1.4% |
| TAYSHA GENE THERAPIES INC | 9 | Q3 2023 | 2.0% |
| CANDEL THERAPEUTICS, INC | 9 | Q3 2023 | 1.3% |
| SPRUCE BIOSCIENCES INC | 9 | Q3 2023 | 0.7% |
| ABSCI CORPORATION | 9 | Q3 2023 | 0.1% |
View Sands Capital Ventures, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-15 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-09 |
View Sands Capital Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.